DEA moves CBD medicines off Schedule 1, a limited expansion of cannabis access

MJBizDaily
By Kristen NicholsSep 27, 2018, 12:58 pm661 ptsTop
The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. It's a decision that immediately affects CBD producers but also signals the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Missouri Campaign Seeks to Allow Cannabis and Hemp Product Sales at Alcohol and Tobacco Retailers 76

Kentucky Gov. Says He Expects Medical Cannabis Dispensaries to Open ‘Before the End of the Year’ 75

Green Blazer: Optimizing RAW Cones Delivery to Manufacturers and Smokers 74

MJBizCon sparks cannabis deals and innovation 60

GOP-Led Congressional Committee Votes To Block Trump From Rescheduling Marijuana 58

Nebraska Medical Cannabis Commission Imposes Plant Limits on Cultivators at Governor’s Request 54

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.